Plain-English translation of NCT05635487 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two approaches to treating HER2-positive breast cancer before surgery: one uses a medication called alone, and another combines with a second medication called maleate. Both approaches aim to shrink the cancer before you have surgery, which may make the operation easier and more effective.
For HER2-positive breast cancer, giving strong medications before surgery (rather than after) can sometimes help reduce the tumor size and improve outcomes. This trial is exploring whether this new medication combination works better than the medication alone.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will receive the study medication (either alone or in combination) as an injection or infusion every two weeks for six cycles, which takes about three months total. Your doctor will check how well the medication is working every two weeks by doing exams and scans. After completing the six cycles of treatment, you will have surgery within four weeks to remove the cancer.
AI-generated summary from trial data ยท Jun 30, 2026 ยท Not medical advice
China